BIOQUÍMICA Y BIOLOGÍA MOLECULAR
Departamento
Elisa
Lozano Esteban
Profesora Titular de Universidad
Publicaciones en las que colabora con Elisa Lozano Esteban (9)
2020
-
Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment
Cancers, Vol. 12, Núm. 9, pp. 1-34
2019
-
Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib
British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800
2018
-
Chemoresistance and chemosensitization in cholangiocarcinoma
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453
-
Genetic heterogeneity of SLC22 family of transporters in drug disposition
Journal of Personalized Medicine, Vol. 8, Núm. 2
-
Molecular bases of the poor response of liver cancer to chemotherapy
Clinics and Research in Hepatology and Gastroenterology
2017
-
Molecular bases of chemoresistance in cholangiocarcinoma
Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900
2016
-
Protective role of biliverdin against bile acid-induced oxidative stress in liver cells
Free Radical Biology and Medicine, Vol. 97, pp. 466-477
2015
-
Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)
Journal of Controlled Release, Vol. 216, pp. 93-102
2012
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704